0001267602-20-000033.txt : 20200303 0001267602-20-000033.hdr.sgml : 20200303 20200303162933 ACCESSION NUMBER: 0001267602-20-000033 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190129 FILED AS OF DATE: 20200303 DATE AS OF CHANGE: 20200303 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ashman Philip CENTRAL INDEX KEY: 0001564990 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-34703 FILM NUMBER: 20682748 MAIL ADDRESS: STREET 1: 6120 WINDWARD PARKWAY, SUITE 290 CITY: ALPHARETTA STATE: GA ZIP: 30005 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALIMERA SCIENCES INC CENTRAL INDEX KEY: 0001267602 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 200028718 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6120 WINDWARD PARKWAY STREET 2: STE 290 CITY: ALPHARETTA STATE: GA ZIP: 30005 BUSINESS PHONE: 678-990-5740 MAIL ADDRESS: STREET 1: 6120 WINDWARD PARKWAY STREET 2: STE 290 CITY: ALPHARETTA STATE: GA ZIP: 30005 4/A 1 wf-form4a_158327095625678.xml FORM 4/A X0306 4/A 2019-01-29 2019-01-31 0 0001267602 ALIMERA SCIENCES INC ALIM 0001564990 Ashman Philip 6120 WINDWARD PARKWAY SUITE 290 ALPHARETTA GA 30005 0 1 0 0 Chief Operating Officer & SVP Common Stock 8146 D On January 31, 2019, the reporting person filed a Form 4 that inadvertently omitted the reporting person's restricted stock unit award reported on Form 4 on January 25, 2019 from the calculation of total amount of securities owned in Column 5. This omission carried through both transactions reported on such Form 4. On November 14, 2019, after the close of business, the issuer effected a one-for-15 reverse stock split. The amount shown in Column 5 above reflects the amount that should have been reported in Column 5 of the original Form 4 after all transactions reported therein, after taking the reverse stock split into account. Without taking the reverse stock split into account, the amount shown in column 5 would have been 122,192 shares. /s/ Philip Ashman 2020-03-03